Sequential ChIP (Re-ChIP) revealed that the enrichment of both E2F4 and p53 occur in cells expressing p53 WT but not in cells expressing p53 R175H, thereby confirming the inability of p53 cancer hotspot mutants to repress DREAM complex targets (Fig. 4G). The gene discussed is E2F4; the disease is cancer.